Question

Difficulty: MediumHealth Screening

An employee health nurse is preparing to administer a Mantoux tuberculin skin test (TST) to a newly hired healthcare worker as part of an occupational health screening protocol. In what order should the nurse perform the following actions? Arrange the steps in the correct chronological sequence.

  1. 1Assess the employee's health record for a documented history of a positive tuberculin skin test.
  2. 2Cleanse a selected site on the volar surface of the forearm with an alcohol swab and let it air dry.
  3. 3Inject the purified protein derivative (PPD) solution intradermally with the needle bevel facing upward.
  4. 4Observe the injection site immediately to confirm the formation of a discrete, pale wheal.
  5. 5Instruct the employee to return to the employee health department in 48 to 72 hours for the test interpretation.

Answer

The correct sequence of steps for administering a tuberculin skin test is to assess for contraindications, prepare the injection site, administer the intradermal injection, verify wheal formation, and instruct the client on follow-up timing.
The sequence reflects the standard nursing process and evidence-based guidelines for administering an intradermal screening test. First, the nurse must perform a targeted assessment to rule out contraindications, such as a history of a positive Mantoux test, which could lead to a severe localized reaction. Once cleared, the nurse prepares the site on the volar forearm using aseptic technique. The administration of the tuberculin solution follows, utilizing a precise 5- to 15-degree angle with the bevel up to ensure intradermal placement. Immediately following the injection, the nurse evaluates the site for the formation of a 6 to 10 mm wheal, which confirms correct technique. Finally, the nurse provides client education regarding the strict 48- to 72-hour timeframe required for an accurate reading of the screening results.

Step-by-Step Solution

1
Assess the client's history for previous positive reactions or severe reactions to the tuberculin skin test.
The nurse confirms the client is a safe candidate for the screening.
Administering a TST to someone with a prior positive result can cause severe hypersensitivity reactions, including tissue necrosis.
2
Cleanse the volar surface of the forearm with an alcohol swab and allow it to dry completely.
The injection site is properly prepared and sanitized.
Cleansing the skin reduces the risk of introducing surface flora into the dermis during the injection.
3
Insert the needle at a 5- to 15-degree angle with the bevel pointing upward and inject the tuberculin solution.
The purified protein derivative (PPD) is deposited into the intradermal space.
The correct angle and bevel position are necessary to ensure the medication stays within the dermal layer rather than going subcutaneously.
4
Confirm the appearance of a 6 to 10 mm pale wheal at the injection site immediately after administration.
The correct intradermal placement of the screening agent is visually verified.
If no wheal forms, or if it is too small, the injection may have been too deep, invalidating the screening test and requiring a repeat injection.
5
Educate the client to return to the healthcare facility in 48 to 72 hours for the screening interpretation.
The client understands the required timeframe for test evaluation.
A TST must be read by a trained professional within the 48- to 72-hour window; otherwise, the screening is invalid and must be repeated.

Key Concept

Tuberculosis Screening and Intradermal Injection Protocol
Rate this question